Three Firms File Identical Results; Rolcon Shows Mixed Performance

SEBIEXCHANGE
Whalesbook Logo
AuthorRiya Kapoor|Published at:
Three Firms File Identical Results; Rolcon Shows Mixed Performance
Overview

Paramount Cosmetics, Sanblue Corporation, and Vinyoflex Limited have reported identical, un-audited financial results for Q3 FY26, raising serious concerns about data integrity and potential regulatory scrutiny. All three saw YoY revenue declines, though Paramount and Sanblue/Vinyoflex turned losses into profits. Rolcon Engineering presented mixed standalone and consolidated results, with a standalone PAT turnaround but a consolidated PAT dip in Q3 FY26. Crucially, no outlook or balance sheet details were disclosed.

📉 The Financial Deep Dive

The latest quarterly filings reveal a deeply concerning pattern for three Indian companies and a mixed bag for another. Paramount Cosmetics (India) Limited, Sanblue Corporation Ltd, and Vinyoflex Limited have all presented identical, un-audited financial results for the quarter and nine months ended December 31, 2025. This anomaly is the most significant development, raising immediate red flags regarding financial reporting standards and potential regulatory oversight.

  • Paramount Cosmetics (India) Limited: Reported total income from operations of ₹955.82 Lakhs for Q3 FY26, a 25.6% YoY decrease from ₹1285.47 Lakhs in Q3 FY25. For the nine months ended December 31, 2025, total income stood at ₹2843.61 Lakhs, down 32% YoY. However, the company achieved a Net Profit After Tax (PAT) of ₹123.26 Lakhs in Q3 FY26, a notable turnaround from a loss of ₹57.82 Lakhs in the prior year's quarter. For the nine months, PAT was ₹286.17 Lakhs, down 17.4% YoY. Basic EPS for Q3 FY26 was ₹2.11 (vs. ₹(0.98) YoY), and for the nine months was ₹4.94 (vs. ₹5.98 YoY).

  • Sanblue Corporation Ltd & Vinyoflex Limited: Both entities presented precisely the same financial figures as Paramount Cosmetics. This includes Q3 FY26 income of ₹955.82 Lakhs (down YoY), and nine-month income of ₹2843.61 Lakhs (down YoY). PAT for Q3 FY26 was ₹123.26 Lakhs (turnaround from loss), and nine-month PAT was ₹286.17 Lakhs (down YoY). Basic EPS stood at ₹2.11 for Q3 FY26 (vs. ₹(0.98) YoY) and ₹4.94 for 9MFY26 (vs. ₹5.98 YoY). The reporting of identical financial data across multiple entities is highly irregular and warrants immediate investigation.

  • Rolcon Engineering Company Limited: Reported standalone total income of ₹1288.71 Lakhs for Q3 FY26, a marginal 0.02% YoY increase from ₹1285.47 Lakhs in Q3 FY25. Standalone income for the nine months declined to ₹3895.37 Lakhs from ₹4426.16 Lakhs YoY (11.9% down). Standalone Net Profit After Tax (PAT) showed significant improvement to ₹35.09 Lakhs in Q3 FY26 from a loss of ₹57.82 Lakhs in Q3 FY25. For 9MFY26, standalone PAT grew 14.9% YoY to ₹238.93 Lakhs from ₹207.91 Lakhs. Standalone Basic EPS was ₹4.64 for Q3 FY26 (vs. ₹(7.65) YoY) and ₹31.60 for 9MFY26 (vs. ₹27.50 YoY). Consolidated results presented a mixed pattern: Q3 FY26 PAT was ₹32.06 Lakhs (47.2% down from ₹60.70 Lakhs YoY), while 9MFY26 PAT increased 16.2% YoY to ₹247.68 Lakhs from ₹213.10 Lakhs YoY. Consolidated EPS for Q3 FY26 was ₹4.24 (vs. ₹(8.03) YoY) and for 9MFY26 was ₹32.76 (vs. ₹28.19 YoY).

The filings also contained a SEBI circular regarding the re-lodgement of transfer requests for physical shares, which is a standard regulatory update. However, no management guidance, outlook, balance sheet, cash flow statements, or order book details were included in these particular financial result extracts, severely limiting any forward-looking analysis.

🚩 Risks & Outlook

The primary risk stems from the identical financial reporting by Paramount Cosmetics, Sanblue Corporation, and Vinyoflex Limited. This raises grave concerns about financial misrepresentation and could lead to significant regulatory action from SEBI, including investigations, penalties, and potential delisting. Investors should exercise extreme caution with these three entities.

For Rolcon Engineering, the divergence between strong standalone PAT growth and a decline in consolidated PAT for Q3 FY26 warrants deeper scrutiny into its subsidiary performance and inter-company transactions. The overall revenue decline in nine-month standalone results also points to potential headwinds.

The absence of management guidance and detailed financial statements (balance sheet, cash flow) makes it impossible to assess the true financial health, liquidity, or future growth prospects of these companies. Investors must await further disclosures or clarifications, especially concerning the anomalous filings. The next 1-2 quarters will be critical for understanding the fallout from these reports and for Rolcon to clarify its consolidated performance.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.